ArticleInternational journal of hematology2016

Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.

Chihiro Shimazaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.